| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31c3812877d9d6605b10e94c37792c7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8bfd608990c37357d85146f05e42e9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b4f16ad70ddfeb0b838c113aaae408a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e80e1332cfe2e270af9617a8d6580a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d89b8ca95cc066837db1f89678672a1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58873f061bd752352629dc78a479bbc4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate |
2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd309bbb24c03bb2c4b4f2403627dfa9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc74422eedad14ae838cc090059aacc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01835c79982a9fc3d3207be4e3d6833c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ff6426903b3261792b6d3593cdcf012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc35e774265759a19355165abbac80ce |
| publicationDate |
2012-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012095054-A1 |
| titleOfInvention |
Polymorphs of esomeprazole salts |
| abstract |
The present invention relates to a high assayed esomeprazole magnesium dihydrate substantially free of its trihydrate form. The present invention further provides an improved and commercially viable process for preparation of high assayed esomeprazole magnesium dihydrate substantially free of its trihydrate form. The present invention also provides an improved process for preparation of pure amorphous esomeprazole magnesium. The present invention further provides an improved and commercially viable process for preparation of substantially enantiomerically pure esomeprazole in neutral form or as a pharmaceutically acceptable salt or as its solvates including hydrates. The present invention also provides solid form of esomeprazole calcium salt, its polymorphs (form 1, form 2 and amorphous form) and processes for their preparation thereof. |
| priorityDate |
2007-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |